1302 related articles for article (PubMed ID: 27799057)
1. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia.
Haroutunian V; Katsel P; Schmeidler J
Neurobiol Aging; 2009 Apr; 30(4):561-73. PubMed ID: 17845826
[TBL] [Abstract][Full Text] [Related]
3. Molecular differences in Alzheimer's disease between male and female patients determined by integrative network analysis.
Sun LL; Yang SL; Sun H; Li WD; Duan SR
J Cell Mol Med; 2019 Jan; 23(1):47-58. PubMed ID: 30394676
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease.
Silva AR; Grinberg LT; Farfel JM; Diniz BS; Lima LA; Silva PJ; Ferretti RE; Rocha RM; Filho WJ; Carraro DM; Brentani H
PLoS One; 2012; 7(11):e48751. PubMed ID: 23144955
[TBL] [Abstract][Full Text] [Related]
5. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
[TBL] [Abstract][Full Text] [Related]
6. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer's disease.
Lin CX; Li HD; Deng C; Liu W; Erhardt S; Wu FX; Zhao XM; Guan Y; Wang J; Wang D; Hu B; Wang J
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34953465
[TBL] [Abstract][Full Text] [Related]
7. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
8. Linking the association between circRNAs and Alzheimer's disease progression by multi-tissue circular RNA characterization.
Lo I; Hill J; Vilhjálmsson BJ; Kjems J
RNA Biol; 2020 Dec; 17(12):1789-1797. PubMed ID: 32618510
[TBL] [Abstract][Full Text] [Related]
9. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Genetic Networks Associated with Alzheimer's Disease.
Zhang B; Tran L; Emilsson V; Zhu J
Methods Mol Biol; 2016; 1303():459-77. PubMed ID: 26235085
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis on preservation patterns of gene co-expression networks during Alzheimer's disease progression.
Ray S; Hossain SMM; Khatun L; Mukhopadhyay A
BMC Bioinformatics; 2017 Dec; 18(1):579. PubMed ID: 29262769
[TBL] [Abstract][Full Text] [Related]
12. Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer's disease.
Chen S; Chang Y; Li L; Acosta D; Li Y; Guo Q; Wang C; Turkes E; Morrison C; Julian D; Hester ME; Scharre DW; Santiskulvong C; Song SX; Plummer JT; Serrano GE; Beach TG; Duff KE; Ma Q; Fu H
Acta Neuropathol Commun; 2022 Dec; 10(1):188. PubMed ID: 36544231
[TBL] [Abstract][Full Text] [Related]
13. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer's disease.
McKenzie AT; Moyon S; Wang M; Katsyv I; Song WM; Zhou X; Dammer EB; Duong DM; Aaker J; Zhao Y; Beckmann N; Wang P; Zhu J; Lah JJ; Seyfried NT; Levey AI; Katsel P; Haroutunian V; Schadt EE; Popko B; Casaccia P; Zhang B
Mol Neurodegener; 2017 Nov; 12(1):82. PubMed ID: 29110684
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.
Chung J; Sahelijo N; Maruyama T; Hu J; Panitch R; Xia W; Mez J; Stein TD; ; Saykin AJ; Takeyama H; Farrer LA; Crane PK; Nho K; Jun GR
Alzheimers Dement; 2023 Nov; 19(11):5173-5184. PubMed ID: 37166019
[TBL] [Abstract][Full Text] [Related]
15. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.
Liang WS; Dunckley T; Beach TG; Grover A; Mastroeni D; Ramsey K; Caselli RJ; Kukull WA; McKeel D; Morris JC; Hulette CM; Schmechel D; Reiman EM; Rogers J; Stephan DA
Physiol Genomics; 2008 Apr; 33(2):240-56. PubMed ID: 18270320
[TBL] [Abstract][Full Text] [Related]
16. Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer's disease.
Morabito S; Miyoshi E; Michael N; Swarup V
Hum Mol Genet; 2020 Oct; 29(17):2899-2919. PubMed ID: 32803238
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains.
Patel H; Hodges AK; Curtis C; Lee SH; Troakes C; Dobson RJB; Newhouse SJ
Brain Behav Immun; 2019 Aug; 80():644-656. PubMed ID: 31063847
[TBL] [Abstract][Full Text] [Related]
18. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.
Hadar A; Milanesi E; Squassina A; Niola P; Chillotti C; Pasmanik-Chor M; Yaron O; Martásek P; Rehavi M; Weissglas-Volkov D; Shomron N; Gozes I; Gurwitz D
Transl Psychiatry; 2016 Oct; 6(10):e909. PubMed ID: 27701409
[TBL] [Abstract][Full Text] [Related]
19. Revealing cell vulnerability in Alzheimer's disease by single-cell transcriptomics.
Saura CA; Deprada A; Capilla-López MD; Parra-Damas A
Semin Cell Dev Biol; 2023 Apr; 139():73-83. PubMed ID: 35623983
[TBL] [Abstract][Full Text] [Related]
20. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Seyfried NT; Dammer EB; Swarup V; Nandakumar D; Duong DM; Yin L; Deng Q; Nguyen T; Hales CM; Wingo T; Glass J; Gearing M; Thambisetty M; Troncoso JC; Geschwind DH; Lah JJ; Levey AI
Cell Syst; 2017 Jan; 4(1):60-72.e4. PubMed ID: 27989508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
